EPRSQ : EPIRUS Biopharmaceuticals stock forecast, predictions, and share price target for 2022, 2023 (1 year) to 2025 - 2027 (5 year) to 2030, and 2032 (10 year) with Revenue and EPS Prognosis by Technical Analysis
| year | Average | Low | High | Change from close on 2022-03-18 |
|---|---|---|---|---|
| 2022 | $0.0 | $0.0 | $0.0 | -37.66% |
| 2023 | $0.0 | $0.0 | $0.0 | -20.69% |
| 2024 | $0.0 | $0.0 | $0.0 | -15.22% |
| 2025 | $0.0 | $0.0 | $0.0 | -5.16% |
| 2026 | $0.0 | $0.0 | $0.0 | -21.25% |
| 2027 | $0.0 | $0.0 | $0.0 | -1.96% |
| 2028 | $0.0 | $0.0 | $0.0 | -12.21% |
| 2029 | $0.0 | $0.0 | $0.0 | 21.48% |
| 2030 | $0.0 | $0.0 | $0.0 | 49.12% |
| 2031 | $0.0 | $0.0 | $0.0 | 42.1% |
| 2032 | $0.0 | $0.0 | $0.0 | 53.44% |
From AI system, total return is 3274.19% from 3845 forecasts.
For EPIRUS Biopharmaceuticals stock forecast for 2022, 9 predictions are offered for each month of 2022 with average EPIRUS Biopharmaceuticals stock
forecast of $0.0, a high forecast of $0.0, and a low forecast of $0.0.
The average EPIRUS Biopharmaceuticals stock forecast 2022 represents a -37.66%
decrease from the last price of $9.99999974737875E-5.
For EPIRUS Biopharmaceuticals stock forecast for 2023, 12 predictions are offered for each month of 2023 with average EPIRUS Biopharmaceuticals stock
forecast of $0.0, a high forecast of $0.0, and a low forecast of $0.0.
The average EPIRUS Biopharmaceuticals stock forecast 2023 represents a -20.69%
decrease from the last price of $9.99999974737875E-5.
For EPIRUS Biopharmaceuticals stock forecast for 2025, 12 predictions are offered for each month of 2025 with average EPIRUS Biopharmaceuticals stock
forecast of $0.0, a high forecast of $0.0, and a low forecast of $0.0.
The average EPIRUS Biopharmaceuticals stock forecast 2025 represents a -5.16%
decrease from the last price of $9.99999974737875E-5.
For EPIRUS Biopharmaceuticals stock forecast for 2027 (5 year), 12 predictions are offered for each month of 2027 with average EPIRUS Biopharmaceuticals stock
forecast of $0.0, a high forecast of $0.0, and a low forecast of $0.0.
The average EPIRUS Biopharmaceuticals stock forecast 2027 represents a -1.96%
decrease from the last price of $9.99999974737875E-5.
For EPIRUS Biopharmaceuticals stock forecast for 2030, 12 predictions are offered for each month of 2030 with average EPIRUS Biopharmaceuticals stock
forecast of $0.0, a high forecast of $0.0, and a low forecast of $0.0.
The average EPIRUS Biopharmaceuticals stock forecast 2030 represents a 49.12%
increase from the last price of $9.99999974737875E-5.
For EPIRUS Biopharmaceuticals stock forecast for 2032 (10 year), 3 predictions are offered for each month of 2032 with average EPIRUS Biopharmaceuticals stock
forecast of $0.0, a high forecast of $0.0, and a low forecast of $0.0.
The average EPIRUS Biopharmaceuticals stock forecast 2032 represents a 53.44%
increase from the last price of $9.99999974737875E-5.
Please, see more forecasts below.
EPIRUS Biopharmaceuticals stock forecast for upcoming days
| Date | Price Target | Change |
|---|---|---|
| 2021-11-22 | $.00 | 6.01% |
| 2021-11-23 | $.00 | 136.32% |
| 2021-11-24 | $.00 | 40.85% |
| 2021-11-25 | $.00 | -11.12% |
| 2021-11-26 | $.00 | -19.90% |
EPRSQ : Long term EPIRUS Biopharmaceuticals stock forecast for 2022, 2023 (1 year) - 2025 - 2027 (5 year) - 2030, and 2032 (10 year)
Forecast for 2022 Apr. is $.00 , for 2023 Mar. is $.00 , for 2026 Mar. is $.00 , for 2027 Mar. is $.00 , for 2031 Mar. is $.00 , and for 2032 Mar. is $.00.
EPRSQ : EPIRUS Biopharmaceuticals stock forecast for 2022
| Date | Price Target | Change |
|---|---|---|
| 2022 Apr. | $.00 | -17.87% |
| 2022 May. | $.00 | -18.57% |
| 2022 Jun. | $.00 | -11.01% |
| 2022 Jul. | $.00 | -3.85% |
| 2022 Aug. | $.00 | -0.21% |
| 2022 Sep. | $.00 | 1.34% |
| 2022 Oct. | $.00 | 1.89% |
| 2022 Nov. | $.00 | 2.06% |
| 2022 Dec. | $.00 | 1.80% |
EPRSQ : EPIRUS Biopharmaceuticals stock forecast for 2023
| Date | Price Target | Change |
|---|---|---|
| 2023 Jan. | $.00 | 1.66% |
| 2023 Feb. | $.00 | 1.28% |
| 2023 Mar. | $.00 | 0.92% |
| 2023 Apr. | $.00 | 11.82% |
| 2023 May. | $.00 | 8.68% |
| 2023 Jun. | $.00 | 5.16% |
| 2023 Jul. | $.00 | 2.91% |
| 2023 Aug. | $.00 | 2.62% |
| 2023 Sep. | $.00 | 3.25% |
| 2023 Oct. | $.00 | 2.78% |
| 2023 Nov. | $.00 | 1.15% |
| 2023 Dec. | $.00 | -1.22% |
EPRSQ : EPIRUS Biopharmaceuticals stock forecast for 2024
| Date | Price Target | Change |
|---|---|---|
| 2024 Jan. | $.00 | -1.76% |
| 2024 Feb. | $.00 | -2.37% |
| 2024 Mar. | $.00 | -2.50% |
| 2024 Apr. | $.00 | -2.02% |
| 2024 May. | $.00 | -0.64% |
| 2024 Jun. | $.00 | 0.08% |
| 2024 Jul. | $.00 | 0.15% |
| 2024 Aug. | $.00 | -0.04% |
| 2024 Sep. | $.00 | -0.10% |
| 2024 Oct. | $.00 | 0.54% |
| 2024 Nov. | $.00 | 1.91% |
| 2024 Dec. | $.00 | 3.71% |
EPRSQ : EPIRUS Biopharmaceuticals stock forecast for 2025
| Date | Price Target | Change |
|---|---|---|
| 2025 Jan. | $.00 | 5.13% |
| 2025 Feb. | $.00 | 5.36% |
| 2025 Mar. | $.00 | 4.76% |
| 2025 Apr. | $.00 | 4.00% |
| 2025 May. | $.00 | 0.79% |
| 2025 Jun. | $.00 | -1.07% |
| 2025 Jul. | $.00 | -3.07% |
| 2025 Aug. | $.00 | -4.86% |
| 2025 Sep. | $.00 | -6.30% |
| 2025 Oct. | $.00 | -7.48% |
| 2025 Nov. | $.00 | -8.51% |
| 2025 Dec. | $.00 | -9.21% |
EPRSQ : EPIRUS Biopharmaceuticals stock forecast for 2026
| Date | Price Target | Change |
|---|---|---|
| 2026 Jan. | $.00 | -8.76% |
| 2026 Feb. | $.00 | -5.66% |
| 2026 Mar. | $.00 | 1.26% |
| 2026 Apr. | $.00 | 8.02% |
| 2026 May. | $.00 | 10.45% |
| 2026 Jun. | $.00 | 9.78% |
| 2026 Jul. | $.00 | 6.86% |
| 2026 Aug. | $.00 | 3.94% |
| 2026 Sep. | $.00 | 1.70% |
| 2026 Oct. | $.00 | 0.12% |
| 2026 Nov. | $.00 | -0.47% |
| 2026 Dec. | $.00 | 0.29% |
EPRSQ : EPIRUS Biopharmaceuticals stock forecast for 2027
| Date | Price Target | Change |
|---|---|---|
| 2027 Jan. | $.00 | 2.17% |
| 2027 Feb. | $.00 | 3.71% |
| 2027 Mar. | $.00 | 3.33% |
| 2027 Apr. | $.00 | 1.51% |
| 2027 May. | $.00 | 0.13% |
| 2027 Jun. | $.00 | 0.29% |
| 2027 Jul. | $.00 | 1.24% |
| 2027 Aug. | $.00 | 2.89% |
| 2027 Sep. | $.00 | 0.37% |
| 2027 Oct. | $.00 | -6.71% |
| 2027 Nov. | $.00 | -9.49% |
| 2027 Dec. | $.00 | -8.10% |
EPRSQ : EPIRUS Biopharmaceuticals stock forecast for 2028
| Date | Price Target | Change |
|---|---|---|
| 2028 Jan. | $.00 | -2.70% |
| 2028 Feb. | $.00 | 5.94% |
| 2028 Mar. | $.00 | 8.83% |
| 2028 Apr. | $.00 | 7.05% |
| 2028 May. | $.00 | 1.64% |
| 2028 Jun. | $.00 | -3.54% |
| 2028 Jul. | $.00 | -5.43% |
| 2028 Aug. | $.00 | -6.40% |
| 2028 Sep. | $.00 | -10.22% |
| 2028 Oct. | $.00 | -3.18% |
| 2028 Nov. | $.00 | 9.52% |
| 2028 Dec. | $.00 | 10.47% |
EPRSQ : EPIRUS Biopharmaceuticals stock forecast for 2029
| Date | Price Target | Change |
|---|---|---|
| 2029 Jan. | $.00 | 8.17% |
| 2029 Feb. | $.00 | 5.85% |
| 2029 Mar. | $.00 | 5.03% |
| 2029 Apr. | $.00 | 5.78% |
| 2029 May. | $.00 | 7.58% |
| 2029 Jun. | $.00 | 5.65% |
| 2029 Jul. | $.00 | 0.35% |
| 2029 Aug. | $.00 | 0.64% |
| 2029 Sep. | $.00 | -0.94% |
| 2029 Oct. | $.00 | -2.82% |
| 2029 Nov. | $.00 | 0.99% |
| 2029 Dec. | $.00 | 3.73% |
EPRSQ : EPIRUS Biopharmaceuticals stock forecast for 2030
| Date | Price Target | Change |
|---|---|---|
| 2030 Jan. | $.00 | 5.35% |
| 2030 Feb. | $.00 | 5.49% |
| 2030 Mar. | $.00 | 3.18% |
| 2030 Apr. | $.00 | 1.22% |
| 2030 May. | $.00 | 0.35% |
| 2030 Jun. | $.00 | 0.00% |
| 2030 Jul. | $.00 | -0.14% |
| 2030 Aug. | $.00 | -0.21% |
| 2030 Sep. | $.00 | -0.42% |
| 2030 Oct. | $.00 | -1.74% |
| 2030 Nov. | $.00 | -7.40% |
| 2030 Dec. | $.00 | -3.75% |
EPRSQ : EPIRUS Biopharmaceuticals stock forecast for 2031
| Date | Price Target | Change |
|---|---|---|
| 2031 Jan. | $.00 | -0.47% |
| 2031 Feb. | $.00 | 0.85% |
| 2031 Mar. | $.00 | 1.81% |
| 2031 Apr. | $.00 | 2.06% |
| 2031 May. | $.00 | 1.48% |
| 2031 Jun. | $.00 | 0.83% |
| 2031 Jul. | $.00 | 0.53% |
| 2031 Aug. | $.00 | 0.38% |
| 2031 Sep. | $.00 | 0.35% |
| 2031 Oct. | $.00 | 0.43% |
| 2031 Nov. | $.00 | 0.42% |
| 2031 Dec. | $.00 | 0.72% |
EPRSQ : EPIRUS Biopharmaceuticals stock forecast for 2032
| Date | Price Target | Change |
|---|---|---|
| 2032 Jan. | $.00 | 1.67% |
| 2032 Feb. | $.00 | 2.29% |
| 2032 Mar. | $.00 | 2.40% |
Financial Data for EPIRUS Biopharmaceuticals stock
Frequently Asked Questions about EPIRUS Biopharmaceuticals stock forecast
Is EPIRUS Biopharmaceuticals a good long term stock?
From EPIRUS Biopharmaceuticals stock forecast , EPIRUS Biopharmaceuticals (EPRSQ) stock cannot be a good investment choice. According to AI Pickup, the EPIRUS Biopharmaceuticals stock price forecast for 2022 Apr. is $8.21277305775274E-5 From EPIRUS Biopharmaceuticals stock forecast , EPIRUS Biopharmaceuticals (EPRSQ) stock cannot be a good investment choice. According to AI Pickup, the EPIRUS Biopharmaceuticals stock price forecast for 2023 Mar. is $6.36562425062402E-5 From EPIRUS Biopharmaceuticals stock forecast , EPIRUS Biopharmaceuticals (EPRSQ) stock cannot be a good investment choice. According to AI Pickup, the EPIRUS Biopharmaceuticals stock price forecast for 2026 Mar. is $6.14242976738997E-5 From EPIRUS Biopharmaceuticals stock forecast , EPIRUS Biopharmaceuticals (EPRSQ) stock cannot be a good investment choice. According to AI Pickup, the EPIRUS Biopharmaceuticals stock price forecast for 2027 Mar. is $9.94252739631404E-5 From EPIRUS Biopharmaceuticals stock forecast , EPIRUS Biopharmaceuticals (EPRSQ) stock can be a good investment choice. According to AI Pickup, the EPIRUS Biopharmaceuticals stock price forecast for 2031 Mar. is $1.37292385049057E-4 From EPIRUS Biopharmaceuticals stock forecast , EPIRUS Biopharmaceuticals (EPRSQ) stock can be a good investment choice. According to AI Pickup, the EPIRUS Biopharmaceuticals stock price forecast for 2032 Mar. is $1.57038648531748E-4
Is EPIRUS Biopharmaceuticals stock overvalued?
EPIRUS Biopharmaceuticals (EPRSQ) stock is expected to go DOWN . Therefore, AI Pickup would say that EPIRUS Biopharmaceuticals (EPRSQ) stock is overvalued.
Will EPIRUS Biopharmaceuticals stock price go up?
No. The EPIRUS Biopharmaceuticals stock price forecast for 2023 Mar. is $6.36562425062402E-5
Is EPIRUS Biopharmaceuticals stock a good buy now?
Since closing price on 2022-03-18 is $9.99999974737875E-5 and forecast for 2023 Mar. is $.00, EPIRUS Biopharmaceuticals stock is not a good 1 year investment.